Entrada Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 02/14/2025 | 4.87 M | $84.13 M | 0.00% | 11.98% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 4.41 M | $76.22 M | 0.00% | 10.85% |
MPM ASSET MANAGEMENT LLC | 02/14/2025 | 4.38 M | $75.75 M | -1.01% | 10.78% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.90 M | $50.19 M | -4.81% | 7.15% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 2.08 M | $36.01 M | 21.56% | 5.12% |
BLACKROCK, INC. | 02/07/2025 | 1.97 M | $34.14 M | 8.32% | 4.86% |
VANGUARD GROUP INC | 02/11/2025 | 1.46 M | $25.32 M | 19.71% | 3.60% |
FMR LLC | 02/13/2025 | 1.40 M | $24.20 M | -19.71% | 3.45% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 1.03 M | $17.84 M | 0.24% | 2.54% |
STEPSTONE GROUP LP | 02/13/2025 | 761,277 | $13.16 M | 0.00% | 1.87% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 584,955 | $10.11 M | 0.00% | 1.44% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 573,891 | $9.93 M | -0.44% | 1.41% |
STATE STREET CORP | 02/14/2025 | 504,979 | $8.73 M | 7.53% | 1.24% |
NORTHERN TRUST CORP | 02/14/2025 | 318,177 | $5.50 M | 28.46% | 0.78% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 285,272 | $4.93 M | 237.74% | 0.70% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 222,520 | $3.85 M | 123.20% | 0.55% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 217,006 | $3.75 M | 127.45% | 0.53% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 212,717 | $3.68 M | 5.41% | 0.52% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 197,127 | $3.41 M | 5.99% | 0.49% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 166,200 | $2.87 M | 77.19% | 0.41% |
MOORE CAPITAL MANAGEMENT, LP | 02/14/2025 | 105,000 | $1.82 M | 0.00% | 0.26% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 101,358 | $1.75 M | -3.44% | 0.25% |
FEDERATED HERMES, INC. | 02/13/2025 | 99,814 | $1.73 M | 3,104.30% | 0.25% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 87,506 | $1.51 M | -32.62% | 0.22% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 85,621 | $1.48 M | -38.23% | 0.21% |
MORGAN STANLEY | 02/14/2025 | 81,873 | $1.42 M | -12.22% | 0.20% |
FIRST TRUST ADVISORS LP | 02/13/2025 | 73,749 | $1.28 M | -9.56% | 0.18% |
CITADEL ADVISORS LLC | 02/14/2025 | 70,669 | $1.22 M | -19.90% | 0.17% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 67,384 | $1.17 M | -2.90% | 0.17% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 59,710 | $1.03 M | 17.71% | 0.15% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 56,557 | $977,871 | -0.52% | 0.14% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 55,517 | $959,000 | 40.76% | 0.14% |
LPL FINANCIAL LLC | 02/11/2025 | 55,154 | $953,613 | 12.92% | 0.14% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 54,979 | $950,587 | 39.30% | 0.14% |
UBS GROUP AG | 02/14/2025 | 53,091 | $917,943 | 112.44% | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 51,491 | $890,000 | -21.42% | 0.13% |
BARCLAYS PLC | 02/13/2025 | 51,365 | $887,000 | 13.87% | 0.13% |
NAN FUNG GROUP HOLDINGS LTD | 02/13/2025 | 49,082 | $848,628 | 0.00% | 0.12% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 47,788 | $826,255 | 0.00% | 0.12% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 40,624 | $702,389 | 6.61% | 0.10% |
MARTINGALE ASSET MANAGEMENT L P | 02/13/2025 | 38,623 | $667,793 | 1.85% | 0.10% |
RHUMBLINE ADVISERS | 01/30/2025 | 36,731 | $635,069 | 1.19% | 0.09% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 35,750 | $618,118 | 152.54% | 0.09% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 35,721 | $617,616 | 4.87% | 0.09% |
JPMORGAN CHASE & CO | 02/12/2025 | 35,470 | $613,276 | 228.06% | 0.09% |
SWISS NATIONAL BANK | 02/10/2025 | 32,800 | $567,112 | 0.00% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 31,700 | $548,093 | 6.73% | 0.08% |
BAYBRIDGE CAPITAL GROUP, LLC | 01/28/2025 | 28,563 | $493,855 | -1.64% | 0.07% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 28,032 | $484,673 | -17.39% | 0.07% |
WCG WEALTH ADVISORS LLC | 02/19/2025 | 24,030 | $415,000 | 6.21% | 0.06% |
Entrada Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Entrada Therapeutics, Inc.. The most heavily invested institutionals were:
Parallel Advisors, LLC: 0
BAKER BROS. ADVISORS LP: 4.87 M
5AM Venture Management, LLC: 4.41 M
MPM ASSET MANAGEMENT LLC: 4.38 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.9 M
JANUS HENDERSON GROUP PLC: 2.08 M
75.32% of Entrada Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 32.31 M shares in the last 24 months. This purchase volume represents approximately $255.27 M in transactions.